Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Research News
 
RNA Twist: C9ORF72 Intron Expansion Makes Aggregating Protein
8 February 2013. Since the identification of the major ALS and FTLD gene C9ORF72 more than a year ago, scientists have been hunting for clues as to how it promotes disease...
 
Mistaken Identity—Prion Disease or Alzheimer’s on Fast Forward?
8 February 2013. Though considered a strange beast in the grand scheme of brain disorders, could rapidly progressing dementia be more common than scientists think?...
 
Harvard Secures $100M to Study Brain Trauma, Other Football Injuries
8 February 2013. Harvard University will lead a $100 million research effort to study chronic traumatic encephalopathy and a host of other devastating health problems in professional footballers...
 
Research Brief: Octapharma IVIg Iffy in Phase 2 Trial
8 February 2013. Aside from a reasonable safety profile, the first published Phase 2 study of a blood-derived antibody preparation to treat Alzheimer’s disease looks inconclusive at best...
 
GO TO ALL RESEARCH NEWS  
 
 
In the spotlight

Agent Provocateur: C9ORF72 Intron Makes Aggregating Proteins
DPR proteins
in disease
Ever since scientists identified a repeat expansion in an intron of the C9ORF72 gene as the major genetic cause of amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD), they have puzzled over how that mutation promotes disease. In today’s Science, researchers in Germany report the surprising news that the intron expansions are translated.
The proteins contain dipeptide repeats. They aggregate into deposits found in neurons of mutation carriers, but not in people with other types of ALS/FTLD. The discovery suggests that these dipeptide repeat proteins are major pathological players in a subset of ALS/FTLD patients. Scientists in the field hailed the findings as a major advance. Read the full story. Image courtesy of Kohji Mori and Dieter Edbauer
Bulking Up AlzRisk—Database Adds Obesity, Expands Diabetes
AlzRisk diabetes plot
AlzRisk just expanded its girth. The public database of environmental risks for Alzheimer's disease now includes obesity, bringing to 10 the number of factors covered. AlzRisk curators also beefed up the data on diabetes, and improved how search strategies and meta-analyses are displayed. Their analysis strongly suggests obesity in midlife is a risk factor for AD. In late life, when people can lose muscle, the trend reverses, though perhaps for reasons other than body weight itself.For a detailed discussion, read the full story and check out the new AlzRisk obesity entry.
Meeting Probes Latest in AD Imaging Research and Diagnosis
Aβ and white matter integrity
In Miami earlier this month, at the 7th Human Amyloid Imaging conference, experts discussed the latest topics in brain imaging, from tau PET tracers to guidelines on the responsible clinical use of amyloid scans. Unexpected relationships began to emerge
between Aβ deposition and other biomarkers, resurrecting for the moment the question of which comes first—tau or Aβ aggregation? Does cerebrospinal fluid Aβ actually dip before plaque formation? Over the coming days, read Gwyneth Dickey Zakaib's coverage of these topics and more, including the new "centiloid" project, which aims to numerically unify different Aβ tracers.
AD/PD 2013 Registration in Full Swing
Click image
for more details.
As winter stretches into its second, gloomy phase, think spring—think Italy. Register for the largest European conference on Alzheimer's and Parkinson's before current fees go up on 21 February and hotels near the conference venue are booked. Nearly 2,000 abstracts have been submitted, and thought leaders from around the world will discuss current science and research priorities with a large contingent of young investigators, 21 of whom will receive
awards. An imaging satellite meeting will precede the main conference on 5 March 2013.
 
 
What's New

Comments - Posted 8 February 2013
Read remarks by Christopher E. Pearson about Mori K et al.
NEWS: RNA Twist: C9ORF72 Intron Expansion Makes Aggregating Protein
 
Comments - Posted 8 February 2013
Read remarks by Boris Rogelj about Mori K et al.
NEWS: RNA Twist: C9ORF72 Intron Expansion Makes Aggregating Protein
 
Comments - Posted 8 February 2013
Read remarks by Agneta Nordberg about Douaud G et al.
PAPER: Brain Microstructure Reveals Early Abnormalities more than Two Years prior to Clinical Progression from Mild Cognitive Impairment to Alzheimer's Disease.
 
Comments - Posted 7 February 2013
Read remarks by Željko Svedruzic about Coric V et al.
NEWS: Déjà Vu? AD Patients Again Look Worse on γ-Secretase Inhibitor
 
Comments - Posted 6 February 2013
Read remarks by Takaomi Saido about Gold A et al.
PAPER: Enteric alpha-synuclein expression is increased in Parkinson's disease but not Alzheimer's disease.
 
Comments - Posted 6 February 2013
Read remarks by Takaomi Saido about Lehmann M et al.
PAPER: Diverging patterns of amyloid deposition and hypometabolism in clinical variants of probable Alzheimer's disease.
 
Comments - Posted 6 February 2013
Read remarks by Takaomi Saido about Kimura T et al.
PAPER: Pin1 Stimulates Dephosphorylation of Tau at Cdk5-Dependent Alzheimer Phosphorylation Sites.
 
Comments - Posted 6 February 2013
Read remarks by Dennis Selkoe about Yang T et al.
NEWS: New Assays for Aβ Oligomers—Spinal Fluid a Miss, Brain Awash

SEE MORE  
Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
Forum Calendar

AlzGene
PDGene
SZGene
MSGene
ALSGene
An up-to-date collection of all published genetic association studies.
Coalition Against Major Diseases (CAMD)
Visit C-Path's Coalition Against Major Diseases to learn about its collaborative efforts in Alzheimer's and Parkinson's.
C-Path
AlzRisk: An AD Epidemiology Database
The AlzRisk Epidemiology Database provides a publicly available collection of published studies on the impact of putative environmental risk factors and protective factors related to Alzheimer disease in longitudinal cohort studies.
Topics in Neurodegeneration
Download Powerpoint Presentations created by top experts in neurodegenerative disease research. Available for educational or personal use. Edited by Daniel M. Michaelson, PhD, and Tobias Hartmann, PhD.

Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad